Design Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DSGN and other ETFs, options, and stocks.About DSGN
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
CEOPratik Shah
CEOPratik Shah
Employees54
Employees54
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded2017
Founded2017
Employees54
Employees54
DSGN Key Statistics
Market cap315.49M
Market cap315.49M
Price-Earnings ratio-5.04
Price-Earnings ratio-5.04
Dividend yield—
Dividend yield—
Average volume166.24K
Average volume166.24K
High today$5.65
High today$5.65
Low today$5.24
Low today$5.24
Open price$5.65
Open price$5.65
Volume221.80K
Volume221.80K
52 Week high$7.77
52 Week high$7.77
52 Week low$2.60
52 Week low$2.60
People also own
Based on the portfolios of people who own DSGN. This list is generated using Robinhood data, and it’s not a recommendation.